Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00832208
Show Display Options
Rank Status Study
1 Terminated Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL
Condition: Visceral Leishmaniasis
Intervention: Drug: Liposomal amphotericin B (Ambisome)

Study has passed its completion date and status has not been verified in more than two years.